Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia

被引:42
作者
Damtew, Bereket [1 ]
Mengistie, Bezatu [2 ]
Alemayehu, Tadesse [2 ]
机构
[1] Haramaya Univ, Dept Epidemiol & Biostat, Coll Hlth & Med Sci, East Harerge, Ethiopia
[2] Haramaya Univ, Dept Publ Hlth, Coll Hlth & Med Sci, East Harerge, Ethiopia
来源
PAN AFRICAN MEDICAL JOURNAL | 2015年 / 22卷
关键词
HIV; Aids; antiretroviral therapy; Ethiopia;
D O I
10.11604/pamj.2015.22.138.4352
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Studies have shown high initial mortality in Antiretroviral Therapy (ART) programs from resource-limited settings. However, there is dearth of evidence on treatment outcomes and associated determinant factors in public hospitals. Therefore, the objective of this study is to assess survival and identify predictors of death in adult HIV-infected patients initiating ART at a public hospital in Eastern Ethiopia. Methods: A retrospective cohort study was conducted by reviewing baseline and follow-up records of patients who started ART between December 1, 2007 and December 31, 2011 at Kharamara hospital. Time to death was the main outcome measure. Kaplan-Meier models were used to estimate mortality and Cox proportional hazards models to identify predictors of mortality. Results: A total of 784 patients (58.4% females) were followed for a median of 60 months. There were 87 (11.1%) deaths yielding an overall mortality rate of 5.15/100 PYO (95% CI: 4.73-6.37). The estimated mortality was 8.4%, 9.8%, 11.3%, 12.7% and 14.1% at 6, 12, 24, 36 and 48 months respectively. The independent predictors of death were single marital status (AHR: 2.31; 95% CI: 1.18-4.50), a bedridden functional status (AHR: 5.91; 95% CI: 2.87-12.16), advanced WHO stage (AHR: 7.36; 95% CI: 3.17-17.12), BMI < 18.5 Kg/m(2) (AHR: 2.20; 95% CI: 1.18-4.09), CD4 count < 50 cells/mu L (AHR: 2.70; 95% CI: 1.26-5.80), severe anemia (AHR: 4.57; 95% CI: 2.30-9.10), and TB co-infection (AHR: 2.30; 95% CI: 1.28-4.11). Conclusion: Improved survival was observed in patients taking ART in Somali region of Ethiopia. The risk for death was higher in patients with advanced WHO stage, low CD4 count, low Hgb, low BMI, and concomitant TB infection. Intensive case management is recommended for patients with the prognostic factors. Optimal immunologic and weight recoveries in the first 6 months suggest increased effort to retain patients in care at this period.
引用
收藏
页数:8
相关论文
共 22 条
  • [1] Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy Program
    Auld, Andrew F.
    Mbofana, Francisco
    Shiraishi, Ray W.
    Sanchez, Mauro
    Alfredo, Charity
    Nelson, Lisa J.
    Ellerbrock, Tedd
    [J]. PLOS ONE, 2011, 6 (04):
  • [2] Antiretroviral Therapy in the Malawi Defence Force: Access, Treatment Outcomes and Impact on Mortality
    Banda, Alfred C.
    Makombe, Simon D.
    Jahn, Andreas
    Tweya, Hannock
    Chuka, Stuart
    Yu, Joseph Kwong-Leung
    Hedt, Bethany
    Weigel, Ralf
    Nkhata, Amon
    Schouten, Erik J.
    Kamoto, Kelita
    Harries, Anthony D.
    [J]. PLOS ONE, 2008, 3 (01):
  • [3] Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study
    Biadgilign, Sibhatu
    Reda, Ayalu A.
    Digaffe, Tesfaye
    [J]. AIDS RESEARCH AND THERAPY, 2012, 9
  • [4] Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage
    Boerma, JT
    Stanecki, KA
    Newell, ML
    Luo, C
    Beusenberg, M
    Garnett, GP
    Little, K
    Calleja, JG
    Crowley, S
    Kim, JY
    Zaniewski, E
    Walker, N
    Stover, J
    Ghys, PD
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (02) : 145 - 150
  • [5] Canestri Anna, 2007, J Int AIDS Soc, V9, P7, DOI 10.1186/1758-2652-9-4-7
  • [6] CSA ICF, 2011, ETH DEM HLTH SURV
  • [7] FMoH/HAPCO, 2012, COUNTR PROGR REP HIV
  • [8] HAPCO, 2012, HIV AIDS EST PROJ ET
  • [9] Predictors of early death in a cohort of Ethiopian patients treated with HAART
    Jerene, Degu
    Endale, Aschalew
    Hailu, Yewubnesh
    Lindtjorn, Bernt
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [10] Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients
    Jerene D.
    Næss A.
    Lindtjørn B.
    [J]. AIDS Research and Therapy, 3 (1)